Overview

About Our Clinical Publications & Research

For the benefit of current and potential users of EGS surgical devices, we maintain an archive of all clinical and pre-clinical research information available for the devices and pertinent surgical techniques. Abstracts and links to full texts of peer-reviewed publications are provided for easy review.

EGS is committed to developing, marketing and selling clinically safe and effective state-of-the-art surgical products and techniques supported by an ongoing clinical investigation program. In addition to the clinical research already completed, two randomized controlled multicenter studies are currently underway with EsophyX and StomaphyX.

The first study evaluates the relative merits, safety and effectiveness of transoral incisionless fundoplication (TIF) using EsophyX in GERD patients treated with daily proton pump inhibitors (PPIs). The TIF vs. PPIs study is conducted by Dr Blair A Jobe at the University of Pittsburgh Medical Center (UPMC) in Pittsburgh, Pennsylvania, in collaboration with Dr Nicole D Bouvy from the Maastricht University Medical Center in Maastricht, the Netherlands. A total of 120 patients are expected to participate in the study.
For more information on the TIF vs. PPIs study, please go to www.clinicaltrials.gov.

The second study is an IDE study and evaluates the effectiveness of StomaphyX versus sham to reduce weight regained after Roux-en-Y gastric bypass and improve quality of life in obesity. The StomaphyX vs. sham study is conducted by Dr Anita P Courcoulas at the University of Pittsburgh Medical Center in Pittsburgh, Pennsylvania, and Dr Bradley J Needleman at the Ohio State University Medical Center (OSUMC) in Columbus, Ohio. Dr George M Eid and Dr Carole A McCloskey from UPMC and Dr Dean Mikami from OSUMC are co-investigators of the study. A total of 150 patients are expected to participate in the study. For more information on the StomaphyX vs. sham study, please go to www.clinicaltrials.gov.

NP01964-01A